<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d282">
    <sentence id="DDI-DrugBank.d282.s0" text="DOSTINEX should not be administered concurrently with D2-antagonists, such as phenothiazines, butyrophenones, thioxanthines, or metoclopramide.">
        <entity charOffset="0-7" id="DDI-DrugBank.d282.s0.e0" text="DOSTINEX" type="brand"/>
        <entity charOffset="78-91" id="DDI-DrugBank.d282.s0.e1" text="phenothiazines" type="group"/>
        <entity charOffset="94-107" id="DDI-DrugBank.d282.s0.e2" text="butyrophenones" type="group"/>
        <entity charOffset="110-122" id="DDI-DrugBank.d282.s0.e3" text="thioxanthines" type="group"/>
        <entity charOffset="128-141" id="DDI-DrugBank.d282.s0.e4" text="metoclopramide" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d282.s0.e0" e2="DDI-DrugBank.d282.s0.e1" id="DDI-DrugBank.d282.s0.p0" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d282.s0.e0" e2="DDI-DrugBank.d282.s0.e2" id="DDI-DrugBank.d282.s0.p1" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d282.s0.e0" e2="DDI-DrugBank.d282.s0.e3" id="DDI-DrugBank.d282.s0.p2" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d282.s0.e0" e2="DDI-DrugBank.d282.s0.e4" id="DDI-DrugBank.d282.s0.p3" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d282.s0.e1" e2="DDI-DrugBank.d282.s0.e2" id="DDI-DrugBank.d282.s0.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d282.s0.e1" e2="DDI-DrugBank.d282.s0.e3" id="DDI-DrugBank.d282.s0.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d282.s0.e1" e2="DDI-DrugBank.d282.s0.e4" id="DDI-DrugBank.d282.s0.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d282.s0.e2" e2="DDI-DrugBank.d282.s0.e3" id="DDI-DrugBank.d282.s0.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d282.s0.e2" e2="DDI-DrugBank.d282.s0.e4" id="DDI-DrugBank.d282.s0.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d282.s0.e3" e2="DDI-DrugBank.d282.s0.e4" id="DDI-DrugBank.d282.s0.p9"/>
    <negationtags>DOSTINEX should &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be administered concurrently with D2-antagonists, such as phenothiazines, butyrophenones, thioxanthines, or metoclopramide. &lt;/scope&gt;</negationtags></sentence>
</document>